Eli Lilly reported higher fourth-quarter profit on the back of surging demand for its GLP-1 weight-loss drugs.

Feb 3 (Reuters) - Pfizer said on Tuesday its experimental obesity drug, which it acquired through the Metsera deal, showed up ...

Jelly Roll's physical transformation continues, as the country singer has lost nearly 300 lbs. since 2022. Here’s everything ...

By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...

RELATED: The No. 1 Ozempic Side Effect “Nobody Warns About.” ...

The CDC said in a 2024 report that just 2-in-5 young adults are both weight-eligible and adequately active to join the ...

Medicines and Healthcare products Regulatory Agency experts have issued a stern warning over two particular brands ...

Jelly Roll showed off his nearly 300-lb. weight loss at the Pre-Grammy Gala on Jan. 31. He was joined at the event by his ...

In Phase II data released this week, people taking a monthly dose of PF’3944 continued to lose more weight than those on a ...

A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...

Oprah Winfrey's newest book, "Enough," is about her relationship with weight-loss drugs. Since the '90s, she has been ...

Combining hormonal therapy and tirzepatide may lead to the greatest weight loss after menopause, new evidence suggests.